Licepler

Eplerenone, the active ingredient in Licepler, is an aldosterone antagonist presented as an oral tablet for oral use. It is employed to manage high blood pressure and certain forms of heart failure in adult patients.

GNH USA supplies Licepler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality across multiple markets. The company adheres to stringent quality‑assurance protocols and offers flexible logistics to meet the needs of healthcare providers in Europe, Asia, Africa and the Americas.

Eplerenone acts as an aldosterone antagonist, targeting conditions where excess sodium retention and potassium loss contribute to disease.

Hypertension: reduces blood pressure by promoting sodium excretion and vasodilation. Heart failure: improves cardiac remodeling and lowers hospitalization risk in patients with reduced ejection fraction. Post‑myocardial infarction with left ventricular dysfunction: decreases the incidence of cardiovascular death and progression of heart failure.

Adverse reactions may occur with eplerenone therapy.

Common Side Effects: - Hyperkalaemia: elevated serum potassium levels. - Dizziness or light‑headedness, especially after standing. - Headache. - Gastrointestinal discomfort such as nausea or abdominal pain.

Serious or Rare Side Effects: - Severe hyperkalaemia that can cause cardiac arrhythmia. - Acute renal impairment or worsening kidney function. - Angioedema or severe allergic reactions requiring immediate medical attention.

Before initiating Licepler, several safety considerations should be observed.

Monitor serum potassium: check levels regularly, especially in patients with renal impairment. Assess renal function: evaluate creatinine and eGFR prior to and during treatment. Avoid in patients with hyperkalaemia: contraindicated if serum K⁺ >5.0 mEq/L. Use caution with ACE inhibitors or ARBs: combined therapy increases risk of potassium elevation. Store at ambient temperature: keep in the original container, protect from moisture and light.

Eplerenone may interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - ACE inhibitors or ARBs: combined use can cause dangerous hyperkalaemia. - Potassium‑containing supplements or salt substitutes: additive risk of elevated potassium. - Cyclosporine: may increase serum potassium levels.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: can affect electrolyte balance and require potassium monitoring. - Digoxin: eplerenone may increase digoxin concentrations, necessitating dose adjustment.